mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-11 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |